Frontiers in Genetics is a premier academic journal dedicated to advancing the field of genetics through high-quality, peer-reviewed research. Published by FRONTIERS MEDIA SA in Switzerland since 2010, this Open Access journal provides a platform for researchers and practitioners to disseminate innovative findings across various subfields, including clinical genetics and molecular medicine. With a notable emphasis on interdisciplinary approaches, the journal holds a strong position in the academic landscape, achieving Q2 rankings in key categories such as Genetics and Molecular Medicine in 2023. Not only does Frontiers in Genetics contribute to the scholarly dialogue by publishing impactful studies, but it also promotes accessibility to vital research, ensuring that knowledge is available to a global audience. This journal is a vital resource for researchers, professionals, and students looking to stay at the forefront of genetic discoveries and their applications, reflective of its engagement with contemporary challenges in genetics and healthcare.

Human Genome Variation, published by SpringerNature, is an esteemed open access journal dedicated to the field of genetic research and exploration. Since its inception in 2014, the journal has been at the forefront of advancing our understanding of human genome diversity and its implications in health and disease. With an E-ISSN of 2054-345X, it features a diverse array of studies that encompass biochemistry, genetics, and molecular biology, making it an invaluable resource for researchers and professionals alike. The journal holds a Q3 ranking in both biochemistry and genetics, and a Q4 ranking in molecular biology, highlighting its growing influence within these disciplines. As the landscape of genomics continues to evolve, Human Genome Variation serves as a platform for the dissemination of high-quality research, fostering collaboration and innovation within the scientific community. Researchers and academics are invited to contribute to this pivotal journal, which not only provides open access to its content since 2014 but also aims to bridge the gap between basic research and clinical applications in genetics.

GENETICA is a prominent journal published by SPRINGER, dedicated to advancing the field of genetics and its applications across various biological disciplines, including animal science, plant science, and insect science. Since its inception in 1919, the journal has consistently served as a vital platform for researchers and professionals to disseminate high-quality research findings that explore the genetic bases of biological phenomena. With its current scope spanning from 1943 to 2024, GENETICA holds a commendable position in the academic community, as evidenced by its Q2 ranking in both animal science and insect science, and its active contribution to interdisciplinary studies in genetics. Although the journal does not offer open access, it remains accessible through institutional subscriptions and libraries, ensuring its vital research is widely circulated. Researchers, professionals, and students alike will find GENETICA an invaluable resource for the latest discoveries and methodologies in the ever-evolving landscape of genetics.

Evolutionary Bioinformatics, published by SAGE Publications Ltd, is a pioneering open-access journal established in 2005, dedicated to advancing the field of evolutionary biology through innovative computational techniques and bioinformatics. With an ISSN of 1176-9343, it serves as a critical platform for researchers, professionals, and students to disseminate impactful findings and foster collaboration across disciplines. The journal spans a broad scope, contributing significantly to the areas of Ecology, Evolution, Behavior and Systematics, and Genetics, as evidenced by its respectable Scopus rankings and quartile placements in 2023. With a commitment to providing comprehensive, peer-reviewed research articles and tools for sharing knowledge, Evolutionary Bioinformatics plays an essential role in shaping the future of evolutionary studies and bioinformatics. Readers and contributors alike are encouraged to engage with cutting-edge research that pushes the boundaries of understanding in this dynamic field.

Genetics Research, published by HINDAWI LTD, is a distinguished open access journal that has been at the forefront of genetic studies since its inception in 1960. With the transition to open access in 2019, this journal has expanded its accessibility, fostering knowledge dissemination across the global scientific community. Operating out of the United Kingdom, it provides a platform for innovative research in the fields of genetics and molecular biology, encompassing a broad range of topics that are highly relevant to medical sciences. As of 2023, it holds a Q4 classification in Genetics and a Q3 classification in miscellaneous Medicine, reflecting its ongoing commitment to scholarly excellence amidst shifting academic landscapes. While the journal's H-index remains unlisted, its indexed ranking within Scopus, with a rank of #325/328 in the Genetics category highlights the challenges ligated to its niche audience. Nevertheless, it serves as a crucial resource for researchers, professionals, and students eager to contribute to and stay informed on the latest genetic research trends and breakthroughs.

Bioinformatics Advances, published by Oxford University Press, is an esteemed academic journal that serves as a vital platform for the dissemination of innovative research in the rapidly evolving fields of bioinformatics and computational biology. With a promising E-ISSN of 2635-0041, this journal has made significant strides since its inception in 2021, achieving a commendable Q1 ranking in both the Computer Science Applications and Genetics categories, alongside respectable Q2 rankings in Molecular Biology and Structural Biology as of 2023. Though currently not an open-access publication, its critical insights cater to an audience keen on advancing knowledge and technology in genomic studies and data analytics. The journal emphasizes high-quality research and aims to facilitate the integration of computational techniques within biological sciences, making it an essential resource for researchers, professionals, and students alike who seek to stay at the forefront of bioinformatics advancements.

BIOINFORMATICS, published by Oxford University Press, is a leading journal in the realms of biochemistry, computational mathematics, and computer science, with a notable impact factor that underscores its significance in the field. Since its inception in 1985 and continuing through its expected convergence in 2024, the journal has maintained a prestigious reputation, proudly residing in the Q1 category across multiple disciplines, including molecular biology and statistics. With a Scopus ranking placing it within the top percentiles of its categories, BIOINFORMATICS serves as an essential platform for disseminating high-quality research that advances knowledge and innovation at the intersection of biology and computational sciences. This journal not only offers both subscription and open access options, ensuring wider availability of its cutting-edge research, but it has also become a crucial resource for researchers, professionals, and students aiming to stay at the forefront of bioinformatics and related fields. Explore the latest findings and trends that define the future of biological research through this esteemed publication, any inquiries regarding the journal can be directed to its offices located at Great Clarendon St, Oxford OX2 6DP, England.

International Journal of Genomics is a pivotal open-access publication under the esteemed HINDAWI LTD, dedicated to advancing the fields of genomics, biochemistry, genetics, and molecular biology. Established in 2013, this journal aims to disseminate innovative research findings and foster scholarly dialogue among researchers, professionals, and students alike. With a robust Impact Factor reflective of its commitment to quality, the journal has achieved a Q3 ranking in Biochemistry, Genetics, and Molecular Biology, as well as notable placements in Pharmaceutical Science, indicating its broad relevance and influence in these interconnected fields. The journal is indexed in esteemed databases, ensuring high visibility and accessibility for published works. As an open-access journal, it prioritizes the sharing of knowledge across borders, facilitating greater collaboration and advancement in genomic research globally. Join the academic community in exploring the vast potential of genomics through the International Journal of Genomics, based in Egypt, and reaching audiences worldwide from its London office.

Genes is a leading open-access journal published by MDPI that focuses on advancing the field of genetics and genomics. Established in 2010 and based in Basel, Switzerland, this journal has made significant strides in promoting innovative research in both clinical genetics and molecular biology. With an impact factor reflecting its relevance and quality, Genes has been classified in the Q2 quartile for Genetics and the Q3 quartile for clinical Genetics as of 2023. The journal provides an accessible platform for researchers, professionals, and students to disseminate their findings and explore emerging trends across the genetics landscape. Accessible online since its inception, Genes allows for continuous engagement and collaboration within the scientific community, fostering a deeper understanding of genetic mechanisms and their implications in health and disease.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, published by Mary Ann Liebert, Inc., is a leading peer-reviewed journal dedicated to the field of integrative biology, encompassing Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine. With an ISSN of 1536-2310 and E-ISSN of 1557-8100, this esteemed journal stands out with its commitment to advancing scientific knowledge and research within its scope, particularly effective from its inception in 2002 through to 2024. The journal holds a commendable position in various Scopus ranks, notably achieving a Q2 quartile in Biotechnology and Medicine (miscellaneous), and continues to exemplify rigorous scholarship with an impactful focus on cross-disciplinary integration. Although not an open-access publication, OMICS ensures that its readership has access to significant findings that shape contemporary biological discourse. Researchers, professionals, and students alike are encouraged to contribute to and explore this journal, as it not only advances knowledge but also fosters collaboration among diverse scientific communities.